Related Experiment Video
Updated: Sep 28, 2026

A Novel Contralateral Axillo-Bilateral-Breast Approach for Endoscopic Thyroid Surgery
Published on: July 28, 2026
Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis
Fausto Bogazzi1, Paolo Miccoli, Piero Berti
1Department of Endocrinology and Metabolism, University of Pisa, Cisanello Hospital, Via Paradisa 2, 56124 Pisa, Italy.
Background:
Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal glands (type II AIT) or in the presence of thyroid abnormalities (type I AIT). Sometimes AIT is resistant to conventional treatment. Thyroidectomy was used in patients with AIT, but in patients who are thyrotoxic it may be hazardous. METHODS; Seven patients with AIT (6 type I and 1 type II, 5 men, 2 women, mean age 70 years [range, 60-82 years]) were prepared for total thyroidectomy with a short course of iopanoic acid (1 g/day orally for a mean of 13 days), an oral iodinated cholecystographic agent inhibiting 5'-deiodinase and causing a reduction in the peripheral conversion of thyroxine to triiodothyronine. Mean thyroid volume was 64 mL (range, 10-145 mL).
Results:
Mean serum-free triiodothyronine levels decreased from 20 +/- 16.7 pmol/L to 6 +/- 2 pmol/L (P =.0004), whereas serum-free thyroxine values remained unchanged. Euthyroidism was rapidly (7-20 days) restored, allowing an uncomplicated total thyroidectomy in all patients and the ability to continue amiodarone therapy in 6 patients. None had increased surgical bleeding, recurrent nerve palsy, or hypoparathyroidism. No cardiovascular complications occurred.
Conclusions:
Iopanoic acid is an effective drug allowing rapid control of hyperthyroidism in AIT.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Pharmaceutical Poisoning: Treatment Strategies
Myocarditis IV: Nursing Management
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Angina IV: Management
Myocarditis III: Medical Management
